Cleared Traditional

K172218 - MIM – Y90 Dosimetry

K172218 is an FDA 510(k) clearance for MIM – Y90 Dosimetry, manufactured by Mim Software, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 120-day FDA review.

K172218 · Mim Software, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2017
Decision
120d
Days
Class 2
Risk

K172218 is an FDA 510(k) clearance for the MIM – Y90 Dosimetry. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Mim Software, Inc. (Beachwood, US). The FDA issued a Cleared decision on November 21, 2017 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Mim Software, Inc. devices

FDA 510(k) Submission Details - K172218

510(k) Number K172218 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 24, 2017
Decision Date November 21, 2017
Days to Decision 120 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d slower than avg
Panel avg: 107d · This submission: 120d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1734
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K172218.
Radiomics App v1.0
K173420 · Microsoft Corp. · Dec 2017
Advanced Diffusion Analysis (ADA) application
K173467 · Philips Medical Systems Nederland B.V. · Dec 2017
Merge PACS
K173475 · Merge Healthcare Incorporated · Dec 2017
syngo®.via protoNeo (Version VA20)
K173378 · Siemens Healthcare GmbH · Nov 2017
jFit Surgical Planner
K173329 · Jointvue, LLC · Nov 2017
Planmeca Romexis
K171385 · Planmeca Oy · Nov 2017